DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis.
Translesion synthesis (TLS) is a unique DNA damage tolerance mechanism involved in the replicative bypass of genetic lesions in favor of uninterrupted DNA replication. TLS is critical for the generation of mutations by many different chemical and physical agents, however, there is no information available regarding the role of TLS in carcinogenic metal-induced mutagenesis. Hexavalent chromium (Cr(VI))-containing compounds are highly complex genotoxins possessing both mutagenic and clastogenic activities. The focus of this work was to determine the impact that TLS has on Cr(VI)-induced mutagenesis in Saccharomyces cerevisiae. Wild-type yeast and strains deficient in TLS polymerases (i.e. Polzeta (rev3), Poleta (rad30)) were exposed to Cr(VI) and monitored for cell survival and forward mutagenesis at the CAN1 locus. In general, TLS deficiency had little impact on Cr(VI)-induced clonogenic lethality or cell growth. rad30 yeast exhibited higher levels of basal and induced mutagenesis compared to Wt and rev3 yeast. In contrast, rev3 yeast displayed attenuated Cr(VI)-induced mutagenesis. Moreover, deletion of REV3 in rad30 yeast (rad30 rev3) resulted in a significant decrease in basal and Cr(VI) mutagenesis relative to Wt and rad30 single mutants indicating that mutagenesis primarily depended upon Polzeta. Interestingly, rev3 yeast were similar to Wt yeast in susceptibility to Cr(VI)-induced frameshift mutations. Mutational analysis of the CAN1 gene revealed that Cr(VI)-induced base substitution mutations accounted for 83.9% and 100.0% of the total mutations in Wt and rev3 yeast, respectively. Insertions and deletions comprised 16.1% of the total mutations in Cr(VI) treated Wt yeast but were not observed rev3 yeast. This work provides novel information regarding the molecular mechanisms of Cr(VI)-induced mutagenesis and is the first report demonstrating a role for TLS in the fixation of mutations induced by a carcinogenic metal.
O'Brien
Travis J
TJ
Department of Pharmacology and Physiology, The George Washington University, Washington, DC 20037, USA. phmtjo@gwumc.edu
Witcher
Preston
P
Brooks
Bradford
B
Patierno
Steven R
SR
D026923:Amino Acid Transport Systems, Basic / Q000235:genetics; D001483:Base Sequence; D002857:Chromium / Q000633:toxicity*; D004249:DNA Damage; D004252:DNA Mutational Analysis; D004259:DNA-Directed DNA Polymerase / Q000172:deficiency / Q000378:metabolism; D016368:Frameshift Mutation; D050296:Microbial Viability / Q000187:drug effects; D008969:Molecular Sequence Data; D016296:Mutagenesis / Q000187:drug effects*; D012441:Saccharomyces cerevisiae / Q000166:cytology / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics*; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism; D000099270:Y-Family DNA Polymerases
D026923:Amino Acid Transport Systems, Basic; D002857:Chromium; D004259:DNA-Directed DNA Polymerase; D029701:Saccharomyces cerevisiae Proteins; C502212:CAN1 protein, S cerevisiae; C074702:chromium hexavalent ion; C425929:DNA polymerase zeta; C092602:REV3 protein, S cerevisiae; C112338:Rad30 protein; D000099270:Y-Family DNA Polymerases